VALEANT PHARMACEUTICALS INTL

VRX stock holders 13F

7 superinvestors reported owning VRX (Common Stock) according to the gurus' 2014 Q1 reports.

Top 5 gurus who own (VRX) VALEANT PHARMACEUTICALS INTL

The top 5 super investors (holders) owning VRX (by the percentage (%) of portfolio) are Glenn Greenberg - Brave Warrior Advisors (29.80%), Jeffrey Ubben - ValueAct Holdings (18.84%), Stephen Mandel - Lone Pine Capital (5.22%), Ole Andreas Halvorsen - Viking Global Investors (5.14%) and Nathaniel Simons - Meritage Group (5.10%) as of their 2014 Q1 reports.

To check the latest activities of the top VRX shareholders between value investors, please click on the "Activity" tab.

To see the historical data of VRX's holders please click on the "2014 Q1" dropdown menu and select the date.

# of holders: 7
Period: 2014 Q1
Type: Common Stock
History
Name
Company
% of
Portfolio
Shares*
Price*
Value
% (shares)
Activity
% change to
Portfolio
Daniel Loeb
Third Point
0.52%
250,000
$131.83
$32,958,000
buy
+0.52%
Glenn Greenberg
Brave Warrior Advisors
29.80%
5,592,558
$131.83
$737,267,000
-8.52% (-520,669)
-2.77%
Jeffrey Ubben
ValueAct Holdings
18.84%
18,923,877
$131.83
$2,494,735,000
Nathaniel Simons
Meritage Group
5.10%
1,373,567
$131.83
$181,077,000
-10.14% (-155,036)
-0.58%
Ole Andreas Halvorsen
Viking Global Investors
5.14%
9,296,143
$131.83
$1,225,511,000
+11.61% (+967,139)
+0.53%
Quincy Lee
Ancient Art (Teton Capital)
3.68%
107,890
$131.83
$14,223,000
-25.23% (-36,405)
-1.24%
Stephen Mandel
Lone Pine Capital
5.22%
8,816,702
$131.83
$1,162,306,000
+13.67% (+1,060,217)
+0.63%
AVG reported hold price*: $131.83

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.